Emi Sato

958 total citations
59 papers, 679 citations indexed

About

Emi Sato is a scholar working on Molecular Biology, Dermatology and Reproductive Medicine. According to data from OpenAlex, Emi Sato has authored 59 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Dermatology and 12 papers in Reproductive Medicine. Recurrent topics in Emi Sato's work include Ovarian cancer diagnosis and treatment (9 papers), Dermatology and Skin Diseases (8 papers) and Endometrial and Cervical Cancer Treatments (7 papers). Emi Sato is often cited by papers focused on Ovarian cancer diagnosis and treatment (9 papers), Dermatology and Skin Diseases (8 papers) and Endometrial and Cervical Cancer Treatments (7 papers). Emi Sato collaborates with scholars based in Japan, United States and Mexico. Emi Sato's co-authors include Shinichi Imafuku, Kentaro Nakayama, Masako Ishikawa, Tomoka Ishibashi, Kohei Nakamura, Satoru Kyo, Richard L. Gallo, Hiroshi Katagiri, Ling‐juan Zhang and Christopher A. Adase and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Emi Sato

49 papers receiving 668 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emi Sato Japan 15 242 179 114 99 79 59 679
Ebru Zemheri Türkiye 15 168 0.7× 85 0.5× 129 1.1× 102 1.0× 32 0.4× 109 803
Nair Mk India 20 311 1.3× 79 0.4× 40 0.4× 352 3.6× 34 0.4× 93 1.2k
Yafei Zhang China 14 159 0.7× 150 0.8× 9 0.1× 162 1.6× 42 0.5× 44 706
Surang Triratanachat Thailand 17 289 1.2× 95 0.5× 11 0.1× 97 1.0× 235 3.0× 54 862
Gavin Pickett United States 15 297 1.2× 111 0.6× 15 0.1× 96 1.0× 35 0.4× 18 648
S Thoresen Norway 16 169 0.7× 77 0.4× 22 0.2× 353 3.6× 40 0.5× 28 979
Miyuki Saito Japan 13 180 0.7× 98 0.5× 11 0.1× 209 2.1× 37 0.5× 25 690
F. J. W. Ten Kate Netherlands 18 113 0.5× 61 0.3× 14 0.1× 157 1.6× 73 0.9× 43 1.2k
Tao Xia China 16 191 0.8× 83 0.5× 10 0.1× 233 2.4× 128 1.6× 60 765
Kenji Gonda Japan 15 126 0.5× 318 1.8× 31 0.3× 443 4.5× 18 0.2× 70 847

Countries citing papers authored by Emi Sato

Since Specialization
Citations

This map shows the geographic impact of Emi Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emi Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emi Sato more than expected).

Fields of papers citing papers by Emi Sato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emi Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emi Sato. The network helps show where Emi Sato may publish in the future.

Co-authorship network of co-authors of Emi Sato

This figure shows the co-authorship network connecting the top 25 collaborators of Emi Sato. A scholar is included among the top collaborators of Emi Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emi Sato. Emi Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yasuda, Hiroshi, Mayumi Tsukada, Emi Sato, et al.. (2025). Clinical efficacy of casirivimab and imdevimab in preventing COVID-19 in the Omicron BA.5 subvariant epidemic: a retrospective study. Journal of Pharmaceutical Health Care and Sciences. 11(1). 94–94.
4.
Sato, Emi, et al.. (2024). A case of bullous pemphigoid following administration of anti‐IL‐31 receptor A antibody. The Journal of Dermatology. 51(9). 1252–1255. 13 indexed citations
5.
Sato, Emi, et al.. (2023). Mature IL-36γ Induces Stratum Corneum Exfoliation in Generalized Pustular Psoriasis by Suppressing Corneodesmosin. Journal of Investigative Dermatology. 144(4). 764–773.e4. 5 indexed citations
6.
Sato, Emi, et al.. (2022). Impact of Preoperative Metal Patch Testing on Surgery Using Metal Implants. Arthroplasty Today. 14. 170–174. 4 indexed citations
7.
Sato, Emi, et al.. (2022). Trends in prescriptions of oral medications for psoriasis: A single‐center retrospective study. The Journal of Dermatology. 50(1). 82–88. 1 indexed citations
9.
Sato, Emi, et al.. (2020). Interleukin‐17A suppresses granular layer formation in a 3‐D human epidermis model through regulation of terminal differentiation genes. The Journal of Dermatology. 47(4). 390–396. 9 indexed citations
10.
Katagiri, Hirohisa, Kōichi Nakamura, Emi Sato, et al.. (2019). Telomerase reverse transcriptase (TERT) promoter mutation is a rare event in ovarian clear cell carcinomas in the Japanese population. European Journal of Gynaecological Oncology. 40(2). 220–223. 1 indexed citations
11.
Nakayama, Kentaro, Munmun Rahman, Mohammed Tanjimur Rahman, et al.. (2017). Nucleus accumbens-1/GADD45GIP1 axis mediates cisplatin resistance through cellular senescence in ovarian cancer. Oncology Letters. 13(6). 4713–4719. 8 indexed citations
12.
Sato, Emi, Kentaro Nakayama, Kohei Nakamura, et al.. (2017). Efficacy of metformin for advanced-stage endometrial cancer: A case report. Molecular and Clinical Oncology. 6(3). 441–443. 3 indexed citations
13.
Zhang, Ling‐juan, George L. Sen, Nicole L. Ward, et al.. (2016). Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin Injury. Immunity. 45(1). 119–130. 141 indexed citations
14.
Sato, Emi, Kentaro Nakayama, Masako Ishikawa, et al.. (2016). High-grade serous ovarian cancer 3 years after bilateral salpingectomy: A case report. Molecular and Clinical Oncology. 6(2). 201–203. 4 indexed citations
15.
Nakamura, Kohei, Kentaro Nakayama, Masako Ishikawa, et al.. (2016). The diagnostic utility of PAX8 immunostaining of malignant peritoneal mesothelioma presenting as serous ovarian carcinoma: A single-center report of two cases. Oncology Letters. 13(1). 263–266. 2 indexed citations
16.
Nakamura, Kohei, Kentaro Nakayama, Masako Ishikawa, et al.. (2016). Utility of ovarian biopsy in pancreatic metastasis of high-grade serous ovarian carcinoma: A case report. Molecular and Clinical Oncology. 5(1). 41–43. 3 indexed citations
17.
Nakamura, Kohei, Kentaro Nakayama, Masako Ishikawa, et al.. (2016). High pretreatment plasma D-dimer levels are related to shorter overall survival in endometrial carcinoma. European Journal of Obstetrics & Gynecology and Reproductive Biology. 201. 89–93. 12 indexed citations
18.
Katagiri, Hiroshi, Kentaro Nakayama, Razia Sultana, et al.. (2015). Loss of autophagy-related protein Beclin 1 may define poor prognosis in ovarian clear cell carcinomas. International Journal of Oncology. 47(6). 2037–2044. 21 indexed citations
19.
Rahman, Mohammed Tanjimur, Kentaro Nakayama, Munmun Rahman, et al.. (2013). ESR1 Gene Amplification in Endometrial Carcinomas: A Clinicopathological Analysis. Anticancer Research. 33(9). 3775–3781. 11 indexed citations
20.
Sato, Emi, Shinichi Imafuku, Bin Chou, et al.. (2012). Topical vitamin D3 analogues induce thymic stromal lymphopoietin and cathelicidin in psoriatic skin lesions. British Journal of Dermatology. 167(1). 77–84. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026